Ciloa SAS

About

CILOA'S CUSTOMIZED EXOSOMES FOR INNOVATIVE THERAPEUTICS
Ciloa is the most experienced exosome-based R&D Company dedicated to the development of new high-potential bio-drugs. By overcoming undruggable targets, Ciloa supports your projects to create new therapeutic and new preventive solutions.
Ciloa customizes in vivo exosomes to contain i) fully native membrane protein complexes (GPCRs, Kinase Receptors, Ion Channels, Viral Antigens, Transporters…) embedded in their membrane and ii) chosen cargo proteins inside their cytosol.
Natural properties of exosomes combined with Ciloa in vivo disruptive technology allow to develop:
- VIRUS-FREE candidate THERAPEUTIC VECTORS able to deliver specifically chosen cargos to any diseased organ.
- ANTIBODIES AGAINST UNDRUGGABLE MEMBRANE PROTEIN COMPLEX TARGETS by unlocking all bottlenecks of the antibody development process.
- ADJUVANT & VIRUS-FREE candidate VACCINES, thanks to the combination of perfect antigens with the potent natural adjuvant properties of exosomes.
Ciloa works through Licensing and Partnerships.

Keywords

screening ligand binding to membrane receptors, development of native transmembrane proteins, development of therapeutic antibodies, development of vaccines, development of therapeutic vectors, pioneer of exosome based therapies & vaccines, exosome purification & production

Amenities

No amenities listed yet

Upcoming Events

No upcoming events scheduled

Frequently Asked Questions

No reviews yet. Be the first to review!

Social Links

No social media links available

Photo Gallery

No photos available

Contact Information

Business Info

Location

Business Hours

Business hours not available